DEA Delays MMJ Cannabis Research While Allowing Texas Ibogaine Studies Without Obstruction: The Tale of Two Schedule I Substances
Two Schedule I drugs. Two research tracks. One DEA double standard.MMJ BioPharma Cultivation's FDA sanctioned cannabis research has been stonewalled ...